Please use this identifier to cite or link to this item:
|Title:||Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review.||Austin Authors:||Sim, Bernice L;Sim, Beatrice Z;Tunbridge, Matthew;Liew, David F L ;Robinson, Philip C||Affiliation:||B.L. Sim, BSc, MPH, St George's Hospital Medical School, London, UK.
The University of Queensland Faculty of Medicine, Herston, Queensland, Australia.
Clinical Pharmacology and Therapeutics
The University of Queensland Faculty of Medicine, School of Medicine, Royal Brisbane Hospital Herston, and Royal Brisbane and Women's Hospital, Department of Rheumatology, Herston, Queensland, Australia. email@example.com.
Medicine (University of Melbourne)
|Issue Date:||Mar-2023||metadata.dc.date:||2022||Publication information:||The Journal of Rheumatology 2023||Abstract:||The use of colchicine has been associated with varying degrees of myelosuppression. Despite expanded use in cardiovascular and inflammatory conditions, there remains clinician concern because of potential myelosuppressive side effects. A systematic review was conducted to explore the reported myelosuppressive events of colchicine.||URI:||https://ahro.austin.org.au/austinjspui/handle/1/32301||DOI:||10.3899/jrheum.220524||ORCID:||0000-0002-0536-8715
|Journal:||The Journal of Rheumatology||Start page:||400||End page:||407||PubMed URL:||36319015||Type:||Journal Article||Subjects:||anemia
|Appears in Collections:||Journal articles|
Show full item record
checked on Mar 28, 2023
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.